AMO VITRAX (SODIUM HYALURONATE) VISCOELASTIC SOLUTION

Aid, Surgical, Viscoelastic

FDA Premarket Approval P880031 S013

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to 1) extend the finished product uv absorbance specification from 0. 012 au to 0. 016 au and 2) eliminate the uv absorbance specification from the 24 month shelf-life.

DeviceAMO VITRAX (SODIUM HYALURONATE) VISCOELASTIC SOLUTION
Classification NameAid, Surgical, Viscoelastic
Generic NameAid, Surgical, Viscoelastic
ApplicantABBOTT MEDICAL OPTICS INC
Date Received1999-10-15
Decision Date1999-11-08
PMAP880031
SupplementS013
Product CodeLZP
Advisory CommitteeOphthalmic
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT MEDICAL OPTICS INC 1700 E. St. Andrew Place santa Ana, CA 92705

Supplemental Filings

Supplement NumberDateSupplement Type
P880031Original Filing
S016 2009-01-08 Real-time Process
S015 2008-08-20 30-day Notice
S014 2007-02-15 Normal 180 Day Track
S013 1999-10-15 Real-time Process
S012 1998-02-02 Real-time Process
S011 1995-12-26 Normal 180 Day Track
S010 1995-11-24 Normal 180 Day Track
S009 1995-10-17 Normal 180 Day Track
S008 1994-06-02 Special (immediate Track)
S007 1992-08-21 Normal 180 Day Track
S006 1992-07-02 Normal 180 Day Track
S005 1992-01-15 Normal 180 Day Track
S004 1991-06-12 Normal 180 Day Track
S003
S002
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.